NCT03911310View on ClinicalTrials.gov

[18F]PSMA-11 PET/CT Phase 3 Clinical Study

PHASE3CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

March 20, 2020

Study Completion Date

September 20, 2020

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

[18F]PSMA-11

\[18F\]PSMA-11 PET/CT

DIAGNOSTIC_TEST

[68Ga]PSMA-11

\[68Ga\]PSMA-11 PET/CT

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT03911310 - [18F]PSMA-11 PET/CT Phase 3 Clinical Study | Biotech Hunter | Biotech Hunter